The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

Now, it has decided to publish a special report on two of GSK's COPD therapies – Breo Ellipta (fluticasone furoate and vilanterol) and Trelegy Ellipta ... least one of the drugs being reviewed ...

Approved yesterday by the FDA, Trelegy Ellipta ... therapy for COPD, and could help patients manage their condition better - around a quarter of whom currently use three drugs in separate inhalers.

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14) compared ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...

Novo Nordisk's Ozempic and Wegovy are among 15 drugs targeted for Medicare price negotiations in 2027. The U.S. aims to cut ...